Recently, MT1 was reported to be downregulated in hepatocellular carcinoma and regulated by DNA hypermethylation (29), which may explain why MT1 is downregulated in NASH. This evidence concerns the gene MT1H and metabolic dysfunction-associated steatohepatitis.